Tyrosine Kinases as Druggable Targets in Cancer

Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...

Cijeli opis

Bibliografski detalji

Format:	Online
Jezik:	engleski
Izdano:	IntechOpen 2021
Teme:	Oncology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
Online pristup:	ONIX_20210420_9781789848090_2372
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!